We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Miltefosine to Treat Mucocutaneous Leishmaniasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01050907
Recruitment Status : Completed
First Posted : January 18, 2010
Last Update Posted : March 25, 2015
Sponsor:
Information provided by (Responsible Party):
Knight Therapeutics (USA) Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2015
  Study Completion Date : March 2015